Astera Labs financials
$357.84+1.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $852.5M | $396.3M |
| Gross profit | $645.3M | $302.7M |
| Gross margin | 75.7% | 76.4% |
| Operating income | $173.4M | -$116.1M |
| Net income | $219.1M | -$83.4M |
| Net margin | 25.7% | −21.1% |
| Diluted EPS | $1.22 | $-0.64 |
| EBITDA | $180.3M | -$112.9M |
| Operating cash flow | $319.3M | $136.7M |
| Free cash flow | $281.8M | $102.4M |
| Diluted shares | 179.6M | 131.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $167.6M | $79.6M |
| Short-term investments | $1.02B | $834.8M |
| Total debt | $0.00 | $0.00 |
| Total assets | $1.53B | $1.05B |
| Total liabilities | $168.2M | $89.7M |
| Shareholders' equity | $1.36B | $964.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology